Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$1.86 - $3.36 $217,248 - $392,448
-116,800 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$1.52 - $3.82 $92,720 - $233,020
61,000 Added 109.32%
116,800 $399,000
Q2 2021

Aug 13, 2021

SELL
$2.66 - $3.47 $128,212 - $167,254
-48,200 Reduced 46.35%
55,800 $167,000
Q1 2021

May 17, 2021

BUY
$1.98 - $5.36 $205,920 - $557,440
104,000 New
104,000 $336,000

Others Institutions Holding INFI

About INFINITY PHARMACEUTICALS, INC.


  • Ticker INFI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 89,277,904
  • Description
  • Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...
More about INFI
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.